Martin W Hümmert

12PUBLICATIONS
73CO-AUTHORS
Optical technologyPacific Peoples and disabilityNeurology and neuromuscular diseasesAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 02, 2026
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

|Oct 24, 2025
Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study).

Anna Walz, Daria Tkachenko, Martin W Hümmert

|Jun 10, 2025
Rituximab as First-Line Compared to Escalation Immunotherapy Is Associated With Lower Disability Accumulation in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Cohort Study From Germany and the United Kingdom.

Daniel Engels, Chiara Rocchi, Mirasol Forcadela

|Dec 27, 2024
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD.

Vivien Häußler, Corinna Trebst, Daniel Engels

|Nov 04, 2024
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks.

Carolin Schwake, Theodoros Ladopoulos, Vivien Häußler

|Oct 01, 2024
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort.

Marius Ringelstein, Susanna Asseyer, Gero Lindenblatt

Pageof 2

Frequent Collaborators

8 joint publications

Vivien Häußler

7 joint publications

Joachim Havla

6 joint publications

Marius Ringelstein

6 joint publications

Tania Kümpfel